Pfizer Trial - Search News

Pfizer to seek FDA approval for Lyme vaccine

· 1d · on MSN

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle weakness and pain.

Continue reading

· 1d · on MSN

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Pfizer will seek approval for its Lyme disease vaccine

Pfizer Lyme Disease Vaccine Shows 70% Efficacy, But Misses Statistical Goal

Pfizer and Valneva said on Monday their Lyme disease vaccine showed more than 70% efficacy in a late-stage study, even as it missed its main goal.

Continue reading

Pfizer says Lyme disease vaccine is holding promise

Pfizer-Valneva Lyme vaccine shows more than 70% efficacy but misses key goal